Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01940835 · ClinicalTrials.gov registry record
Role of Intestinal Inflammation in the Pathogenesis of Type 1 Diabetes
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 27
- Enrollment target
NCT01940835: Completed study, sponsored by Mayo Clinic.
NCT01940835 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01940835 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
This purpose of this study is to determine if activation of a person's immune system in the small intestine could be a contributing cause of Type 1 Diabetes.
Interventions
- OTHER Blood draw
- OTHER Stool sample
- PROCEDURE Upper endoscopy with small bowel biopsies and brushings.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2013-09 |
| Est. Completion | 2019-06-19 |
What the finished NCT01940835 record still lists
NCT01940835 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT01940835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01940835 about?
NCT01940835 is a clinical study titled "Role of Intestinal Inflammation in the Pathogenesis of Type 1 Diabetes". This purpose of this study is to determine if activation of a person's immune system in the small intestine could be a contributing cause of Type 1 Diabetes.
What is the current status of trial NCT01940835?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2013-09. Estimated completion is 2019-06-19.
What interventions are being tested in trial NCT01940835?
The interventions under investigation include: Blood draw (OTHER), Stool sample (OTHER), Upper endoscopy with small bowel biopsies and brushings. (PROCEDURE).
Who is sponsoring clinical trial NCT01940835?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia